Imfinzi-based regimens deliver major survival gains in muscle-invasive bladder cancer
The study has shown that perioperative treatment with Imfinzi (durvalumab), alone or in combination with other immunotherapy agents
The study has shown that perioperative treatment with Imfinzi (durvalumab), alone or in combination with other immunotherapy agents
Famotidine Injection USP is a generic version of Pepcid injection to be manufactured at its Nagpur facility for the U.S. market
Darolutamide Tablets, 300 mg, had an estimated market size of US$ 3,155 million in the United States
The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy
Highlighting KEYTRUDA & expanding cancer pipeline
The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
Advanced image-free robotic platform to support greater precision, personalised planning, and improved patient outcomes
Subscribe To Our Newsletter & Stay Updated